Suppression of Early and Late Afterdepolarizations by Heterozygous Knockout of the Na+/Ca2+ Exchanger in a Murine Model.
BACKGROUND
The Na(+)/Ca(2+) exchanger (NCX) has been implied to cause arrhythmias. To date, information on the role of NCX in arrhythmogenesis derived from models with increased NCX expression, hypertrophy, and heart failure. Furthermore, the exact mechanism by which NCX exerts its potentially proarrhythmic effect, ie, by promoting early afterdepolarization (EAD) or delayed afterdepolarization (DAD) or both, is unknown.


RESULTS
We investigated isolated cardiomyocytes from a murine model with heterozygous knockout of NCX (hetKO) using the patch clamp and Ca(2+) imaging techniques. Action potential duration was shorter in hetKO with IKtot not being increased. The rate of spontaneous Ca(2+) release events and the rate of DADs were unaltered; however, DADs had lower amplitude in hetKO. A DAD triggered a spontaneous action potential significantly less often in hetKO when compared with wild-type. The occurrence of EADs was also drastically reduced in hetKO. ICa activity was reduced in hetKO, an effect that was abolished in the presence of the Ca(2+) buffer BAPTA.


CONCLUSIONS
Genetic suppression of NCX reduces both EADs and DADs. The following molecular mechanisms apply: (1) Although the absolute number of DADs is unaffected, an impaired translation of DADs into spontaneous action potentials results from a reduced DAD amplitude. (2) EADs are reduced in absolute number of occurrence, which is presumably a consequence of shortened action potential duration because of reduced NCX activity but also reduced ICa the latter possibly being caused by a direct modulation of Ca(2+)-dependent ICa inhibition by reduced NCX activity. This is the first study to demonstrate that genetic inhibition of NCX protects against afterdepolarizations and to investigate the underlying mechanisms.
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.). nils.boegeholz@ukmuenster.de.
Nils
N
Bögeholz
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Paul
P
Pauls
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
B Klemens
BK
Bauer
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Jan S
JS
Schulte
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Dirk G
DG
Dechering
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Gerrit
G
Frommeyer
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Uwe
U
Kirchhefer
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Joshua I
JI
Goldhaber
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Frank U
FU
Müller
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Lars
L
Eckardt
From the Division of Electrophysiology, Department of Cardiovascular Medicine (N.B., P.P., B.K.B., D.G.D., G.F., L.E., C.P.) and Institute of Pharmacology and Toxicology (P.P., B.K.B., J.S.S., U.K., F.U.M.), University Hospital Münster, Münster, Germany; and Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA (J.I.G.).
Christian
C
Pott
D000200:Action Potentials / Q000502:physiology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000235:genetics / Q000378:metabolism*; D004195:Disease Models, Animal; D006333:Heart Failure / Q000378:metabolism / Q000503:physiopathology; D006579:Heterozygote; D015151:Immunoblotting; D051379:Mice; D018345:Mice, Knockout; D032383:Myocytes, Cardiac / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D019831:Sodium-Calcium Exchanger / Q000235:genetics / Q000378:metabolism*
D019831:Sodium-Calcium Exchanger
Na+/Ca2+ exchanger; action potentials; arrhythmias, cardiac; heart failure